Evidence map›Paper›PMID 20618948›Full record

ArticleBMC cancer2010

Deregulation of manganese superoxide dismutase (SOD2) expression and lymph node metastasis in tongue squamous cell carcinoma.

Xiqiang Liu, Anxun Wang, Lorenzo Lo Muzio, Antonia Kolokythas, Shihu Sheng, Corrado Rubini, Hui Ye, Fei Shi, Tianwei Yu, David L Crowe and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 3 countries.

Xiqiang LiuCenter for Molecular Biology of Oral Diseases, College of Dentistry, University of Illinois at Chicago, IL, USA.
Anxun Wang
Lorenzo Lo Muzio
Antonia Kolokythas
Shihu Sheng
Corrado Rubini
Hui Ye
Fei Shi
Tianwei Yu
David L Crowe
Xiaofeng Zhou
University of Illinois Chicago · USSun Yat-sen University · CNEmory University · USMarche Polytechnic University · ITThe First Affiliated Hospital, Sun Yat-sen University · CNUniversity of Foggia · IT

Funding

Molecular Determinants of Oral Tongue Cancer MetastasisR01CA139596 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WONG, DAVID T, ZHOU, XIAOFENG · 2008 to 2012
$1.7M
Genomic Predictors of Oral Premalignancy ProgressionK22DE014847 · NIDCR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHOU, XIAOFENG · 2004 to 2009
$619k
microRNA signatures of tobacco carcinogen induced oral cancerR03CA135992 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ZHOU, XIAOFENG · 2009 to 2010
$157k
NCI NIH HHS CA135992NCI NIH HHS CA139596NIDCR NIH HHS DE014847
6 · The paper itself

Abstract

backgroundLymph node metastasis is a critical event in the progression of tongue squamous cell carcinoma (TSCC). The identification of biomarkers associated with the metastatic process would provide critical prognostic information to facilitate clinical decision making. Previous studies showed that deregulation of manganese superoxide dismutase (SOD2) expression is a frequent event in TSCC and may be associated with enhanced cell invasion. The purpose of this study is to further evaluate whether the expression level of SOD2 is correlated with the metastatic status in TSCC patients.

methodsWe first examined the SOD2 expression at mRNA level on 53 TSCC and 22 normal control samples based on pooled-analysis of existing microarray datasets. To confirm our observations, we examined the expression of SOD2 at protein level on an additional TSCC patient cohort (n = 100), as well as 31 premalignant dysplasias, 15 normal tongue mucosa, and 32 lymph node metastatic diseases by immunohistochemistry (IHC).

resultsThe SOD2 mRNA level in primary TSCC tissue is reversely correlated with lymph node metastasis in the first TSCC patient cohort. The SOD2 protein level in primary TSCC tissue is also reversely correlated with lymph node metastasis in the second TSCC patient cohort. Deregulation of SOD2 expression is a common event in TSCC and appears to be associated with disease progression. Statistical analysis revealed that the reduced SOD2 expression in primary tumor tissue is associated with lymph node metastasis in both TSCC patient cohorts examined.

conclusionsOur study suggested that the deregulation of SOD2 in TSCC has potential predictive values for lymph node metastasis, and may serve as a therapeutic target for patients at risk of metastasis.

Indexed as

AdultAgedAged, 80 and overCarcinoma, Squamous CellCohort StudiesFemaleHumansImmunoenzyme TechniquesLymphatic MetastasisMaleMiddle AgedPrognosisReverse Transcriptase Polymerase Chain ReactionRNA, MessengerSuperoxide DismutaseSuperoxide Dismutase 2RNA, MessengerSuperoxide DismutaseSuperoxide Dismutase 2

Identifiers

PMID20618948
PMCPMC2911422
OpenAlexW1993514213

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.